Rani Therapeutics surges on Chugai licensing deal, private placement
Source: SeekingAlpha
2025-10-17 09:56:27 ET
More on Rani Therapeutics, Chugai Pharmaceutical Co., Ltd.
- Chugai Pharmaceutical Co., Ltd. 2025 Q2 - Results - Earnings Call Presentation
- Chugai Pharmaceutical Co., Ltd. (CHGCF) Q2 2025 Earnings Call Transcript
- Rani Therapeutics secures $60.3M in private placement to fund pipeline through 2028
- Trump’s 100% drug tariffs send pharma stocks lower
- Seeking Alpha’s Quant Rating on Rani Therapeutics
Read the full article on Seeking Alpha
For further details see:
Rani Therapeutics surges on Chugai licensing deal, private placement
Chugai Pharmaceuticals Co. Ltd. ADR
NASDAQ: CHGCY
CHGCY Trading
0.43% G/L:
$30.13 Last:
59,797 Volume:
$30.02 Open:
CHGCY Latest News
CHGCY Stock Data
$96,444,219,781
3,258,139,484
N/A
8
N/A
Pharmaceuticals
Healthcare
JP
Chuo-Ku
